JPMorgan Private Bank on How to Balance AI Exposure
Madison Faller, investment strategist at JPMorgan Private Bank, says investors can balance AI exposure with quality credit and real assets. She speaks on Bloomberg Television.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Madison Faller, investment strategist at JPMorgan Private Bank, says investors can balance AI exposure with quality credit and real assets. She speaks on Bloomberg Television.
Cementos Pacasmayo (NYSE:CPAC) reported third-quarter 2026 EBITDA of S/233.1 million, up 45.1% from the same quarter in 2025, as revenue and sales volumes increased.
Daiichi Sankyo and AstraZeneca (NASDAQ:AZN) received European Union approval for Enhertu as an adjuvant treatment for eligible adults with HER2-positive early breast cancer and residual invasive disease after neoadjuvant treatment.
NVIDIA (NASDAQ:NVDA) plans to invest $3 billion in Meta’s equity offering as the companies expand their collaboration on AI models, computing infrastructure and agent development.
Guy Johnson, Oliver Crook and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."
Pharming Group (NASDAQ:PHAR) reported preliminary third-quarter 2026 revenue of $117.6 million, up 21% year over year, as operating profit rose 89% to $29.9 million.
Innate Pharma (NASDAQ:IPHA) announced that high-level data from the PACIFIC-9 Phase 3 trial are now expected in the first half of 2027, following a timeline revision by AstraZeneca (NYSE:AZN).
TechTarget (NASDAQ:TTGT), operating as Informa TechTarget, reported underlying revenue growth of -1.6% for the nine months ended September 30, 2026, as technology customers shifted spending priorities toward artificial intelligence.
CoreWeave (NASDAQ:CRWV) has expanded its global AI infrastructure by bringing most of its planned 22.5 megawatts of IT capacity online in Denmark and extending its network into the Middle East and Asia Pacific.
Cellectis (NASDAQ:CLLS) presented preclinical data for HEAL-101, a gene-editing candidate for severe hypertriglyceridemia, reporting approximately 90% mean editing in human liver cells.
Anthropic is expected to raise more money in its initial public offering than any company in history and plans to list on the Nasdaq under the ticker ANT. Its public market performance might cement or capsize Wall Street's confidence in the AI boom at a moment when investors are increasingly anxious about the borrowing binge underpinning it. Matt Bloxham of Bloomberg Intelligence has the details.
Sama Bilbao y Leon, Director General of the World Nuclear Association, says China's 59 reactors under construction demonstrate a programmatic approach to nuclear development that Western Europe and North America should look to replicate.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade